(Q44291625)

1 December 2017

Comparison of different HMG-CoA reductase inhibitors (English)

1 reference

1 December 2017

H H Ditschuneit

1

1 reference

PubMed ID

1904357

1 December 2017

K Kuhn

series ordinal

2

1 reference

PubMed ID

1904357

1 December 2017

H Ditschuneit

series ordinal

3

1 reference

1 December 2017

1 January 1991

1 reference

European Journal of Clinical Pharmacology

1 December 2017

1 reference

1 December 2017

40 Suppl 1

1 reference

1 December 2017

S27-32

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01409404

1 December 2017

0 references

cites work

A receptor-mediated pathway for cholesterol homeostasis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01409404

Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01409404

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

21 January 2018

1 reference

12 December 2020

Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II

1 reference

12 December 2020

Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study

1 reference

12 December 2020

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

12 December 2020

Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia

1 reference

12 December 2020

A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III

1 reference

12 December 2020

Long term administration of lovastatin in the treatment of hypercholesterolaemia

1 reference

12 December 2020

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

12 December 2020

Influence of mevinolin on metabolism of low density lipoproteins in primary moderate hypercholesterolemia

1 reference

12 December 2020

Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia

1 reference

12 December 2020

Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01409404

1 reference

1 December 2017

1 reference

PubMed ID

1904357